| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab127668-10μl | 10μl | In stock | $69.90 | |
| Ab127668-50μl | 50μl | In stock | $189.90 | |
| Ab127668-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $299.90 | |
| Ab127668-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,699.90 |
Recombinant; Rabbit anti Human SIRT2 Antibody; WB, IHC; Unconjugated
| Product Name | Recombinant SIRT2 Antibody - Primary antibody, specific to SIRT2, Rabbit IgG |
|---|---|
| Synonyms | EC 2.3.1.286 | Regulatory protein SIR2 homolog 2 | SIR2-like protein 2 | FLJ35621 antibody | FLJ37491 antibody | NAD dependent deacetylase sirtuin 2 antibody | NAD dependent protein deacetylase sirtuin 2 antibody | NAD-dependent deacetylase sirtuin-2 anti |
| Specifications & Purity | ExactAb™, Validated, Recombinant, 0.5 mg/mL |
| Host species | Rabbit |
| Specificity | SIRT2 |
| Immunogen | Recombinant protein of human SIRT2 (AA 2-389) |
| Positive Control | WB: HeLa and NIH/3T3 cell lysates. IHC: Human colon cancer tissue. |
| Conjugation | Unconjugated |
| Grade | ExactAb™, Recombinant, Validated |
| Product Description |
Rabbit anti Human SIRT2 Antibody, Recombinant, could be used for WB, IHC and so on. |
| Isotype | Rabbit IgG |
|---|---|
| SDS-PAGE | 150 kDa |
| Purification Method | Antigen affinity purified |
| Form | Liquid |
| Concentration | 0.5 mg/mL |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Recombinant SIRT2 Antibody (Ab127668) - Western Blot
All lanes: Recombinant SIRT2 Antibody (Ab127668) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 42 kDa
Exposure time: 15.7 s
Recombinant SIRT2 Antibody (Ab127668) - IHC
Immunohistochemistry analysis of paraffin-embedded Human colon cancer using Recombinant SIRT2 Antibody (Ab127668). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Application | Dilution info |
|---|---|
| WB | 1/500-1/2000 "> 1/500-1/2000 |
| IHC | 1/50 - 1/100 "> 1/50 - 1/100 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0403989 | Certificate of Analysis | Apr 01, 2024 | Ab127668 |
| ZJ24F0403988 | Certificate of Analysis | Apr 01, 2024 | Ab127668 |
| 1. Cole PA. (2008) Chemical probes for histone-modifying enzymes.. Nat Chem Biol, 4 (10): (590-7). [PMID:18800048] [10.1021/op500134e] |
| 2. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB et al.. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.. Nature, 450 (7170): (712-6). [PMID:18046409] [10.1021/op500134e] |
| 3. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ et al.. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.. Science, 317 (5837): (516-9). [PMID:17588900] [10.1021/op500134e] |
| 4. Pasco MY, Rotili D, Altucci L, Farina F, Rouleau GA, Mai A, Néri C. (2010) Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.. J Med Chem, 53 (3): (1407-11). [PMID:20041717] [10.1021/op500134e] |
| 5. Maurer B, Rumpf T, Scharfe M, Stolfa DA, Schmitt ML, He W, Verdin E, Sippl W, Jung M. (2012) Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.. ACS Med Chem Lett, 3 (12): (1050-3). [PMID:24900427] [10.1021/op500134e] |
| 6. Cai X, Zhai HX, Wang J, Forrester J, Qu H, Yin L, Lai CJ, Bao R, Qian C. (2010) Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.. J Med Chem, 53 (5): (2000-9). [PMID:20143778] [10.1021/op500134e] |
| 7. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R. (2016) Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.. Eur J Med Chem, 109 (13): (216-37). [PMID:26774927] [10.1021/op500134e] |
| 8. Ai T, Wilson DJ, More SS, Xie J, Chen L. (2016) 5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.. J Med Chem, 59 (7): (2928-41). [PMID:26982234] [10.1021/op500134e] |
| 9. Finnin MS, Donigian JR, Pavletich NP. (2001) Structure of the histone deacetylase SIRT2.. Nat Struct Biol, 8 (7): (621-5). [PMID:11427894] [10.1021/op500134e] |
| 10. Pandithage R, Lilischkis R, Harting K, Wolf A, Jedamzik B, Lüscher-Firzlaff J, Vervoorts J, Lasonder E, Kremmer E, Knöll B et al.. (2008) The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.. J Cell Biol, 180 (5): (915-29). [PMID:18332217] [10.1021/op500134e] |
| 11. Antonello Mai,Sergio Valente,Sarah Meade,Vincenzo Carafa,Maria Tardugno,Angela Nebbioso,Andrea Galmozzi,Nico Mitro,Emma De Fabiani,Lucia Altucci,Aleksey Kazantsev. (2009-08-12) Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.. Journal of medicinal chemistry, 52 ((17)): (5496-5504). [PMID:19663498] |
| 12. Takayoshi Suzuki,Tomomi Asaba,Erika Imai,Hiroki Tsumoto,Hidehiko Nakagawa,Naoki Miyata. (2009-08-25) Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.. Bioorganic & medicinal chemistry letters, 19 ((19)): (5670-5672). [PMID:19700324] |
| 13. Haig A Eskandarian,Francis Impens,Marie-Anne Nahori,Guillaume Soubigou,Jean-Yves Coppée,Pascale Cossart,Mélanie A Hamon. (2013-08-03) A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection.. Science (New York, N.Y.), 341 ((6145)): (1238858-1238858). [PMID:23908241] |
| 14. Yi-Pei Chen,Chad C Catbagan,Jeannette T Bowler,Trevor Gokey,Natalie D M Goodwin,Anton B Guliaev,Weiming Wu,Taro Amagata. (2013-11-26) Evaluation of benzoic acid derivatives as sirtuin inhibitors.. Bioorganic & medicinal chemistry letters, 24 ((1)): (349-352). [PMID:24269123] |
| 15. Tatsiana Kosciuk,Ian R Price,Xiaoyu Zhang,Chengliang Zhu,Kayla N Johnson,Shuai Zhang,Steve L Halaby,Garrison P Komaniecki,Min Yang,Caroline J DeHart,Paul M Thomas,Neil L Kelleher,J Christopher Fromme,Hening Lin. (2020-02-28) NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle.. Nature communications, 11 ((1)): (1067-1067). [PMID:32103017] |
| 16. Sharon Gauci,Andreas O Helbig,Monique Slijper,Jeroen Krijgsveld,Albert J R Heck,Shabaz Mohammed. (2009-05-06) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.. Analytical chemistry, 81 ((11)): (4493-4501). [PMID:19413330] |
| 17. Brandi D Sanders,Brittany Jackson,Michael Brent,Alexander M Taylor,Weiwei Dang,Shelley L Berger,Stuart L Schreiber,Konrad Howitz,Ronen Marmorstein. (2009-09-08) Identification and characterization of novel sirtuin inhibitor scaffolds.. Bioorganic & medicinal chemistry, 17 ((19)): (7031-7041). [PMID:19734050] |
| 18. Taki Sakai,Yotaro Matsumoto,Minoru Ishikawa,Kazuyuki Sugita,Yuichi Hashimoto,Nobuhiko Wakai,Akio Kitao,Era Morishita,Chikashi Toyoshima,Tomoatsu Hayashi,Tetsu Akiyama. (2014-12-18) Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.. Bioorganic & medicinal chemistry, 23 ((2)): (328-339). [PMID:25515955] |
| 19. Mai A, Cheng D, Bedford MT, Valente S, Nebbioso A, Perrone A, Brosch G, Sbardella G, De Bellis F, Miceli M, Altucci L.. (2008) epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.. J Med Chem, 51 (7): (2279-2290). [PMID:18348515] [10.1021/jm701595q] |
| 20. Medda F, Russell RJ, Higgins M, McCarthy AR, Campbell J, Slawin AM, Lane DP, Lain S, Westwood NJ.. (2009) Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.. J Med Chem, 52 (9): (2673-2682). [PMID:19419202] [10.1021/jm8014298] |
| 21. Rotili D, Carafa V, Tarantino D, Botta G, Nebbioso A, Altucci L, Mai A.. (2011) Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.. Bioorg Med Chem, 19 (12): (3659-3668). [PMID:21306905] [10.1016/j.bmc.2011.01.025] |
| 22. Huber K, Superti-Furga G.. (2011) After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.. Bioorg Med Chem, 19 (12): (3616-3624). [PMID:21306906] [10.1016/j.bmc.2011.01.018] |
| 23. Hirsch BM, Hao Y, Li X, Wesdemiotis C, Wang Z, Zheng W.. (2011) A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).. Bioorg Med Chem Lett, 21 (16): (4753-4757). [PMID:21752644] [10.1016/j.bmcl.2011.06.069] |
| 24. McCarthy AR, Pirrie L, Hollick JJ, Ronseaux S, Campbell J, Higgins M, Staples OD, Tran F, Slawin AM, Lain S, Westwood NJ.. (2012) Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.. Bioorg Med Chem, 20 (5): (1779-1793). [PMID:22304848] [10.1016/j.bmc.2012.01.001] |
| 25. Choi SH, Quinti L, Kazantsev AG, Silverman RB.. (2012) 3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2).. Bioorg Med Chem Lett, 22 (8): (2789-2793). [PMID:22446090] [10.1016/j.bmcl.2012.02.089] |
| 26. Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N.. (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.. J Med Chem, 55 (12): (5760-5773). [PMID:22642300] [10.1021/jm3002108] |
| 27. Fridén-Saxin M, Seifert T, Landergren MR, Suuronen T, Lahtela-Kakkonen M, Jarho EM, Luthman K.. (2012) Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.. J Med Chem, 55 (16): (7104-7113). [PMID:22746324] [10.1021/jm3005288] |
| 28. Rotili D, Tarantino D, Carafa V, Paolini C, Schemies J, Jung M, Botta G, Di Maro S, Novellino E, Steinkühler C, De Maria R, Gallinari P, Altucci L, Mai A.. (2012) Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.. J Med Chem, 55 (18): (8193-8197). [PMID:22931526] [10.1021/jm301115r] |
| 29. Rotili D, Tarantino D, Nebbioso A, Paolini C, Huidobro C, Lara E, Mellini P, Lenoci A, Pezzi R, Botta G, Lahtela-Kakkonen M, Poso A, Steinkühler C, Gallinari P, De Maria R, Fraga M, Esteller M, Altucci L, Mai A.. (2012) Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.. J Med Chem, 55 (24): (10937-10947). [PMID:23189967] [10.1021/jm3011614] |
| 30. Amagata T, Xiao J, Chen YP, Holsopple N, Oliver AG, Gokey T, Guliaev AB, Minoura K.. (2012) Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.. J Nat Prod, 75 (12): (2193-2199). [PMID:23167691] [10.1021/np300640g] |
| 31. Salo HS, Laitinen T, Poso A, Jarho E, Lahtela-Kakkonen M.. (2013) Identification of novel SIRT3 inhibitor scaffolds by virtual screening.. Bioorg Med Chem Lett, 23 (10): (2990-2995). [PMID:23562596] [10.1016/j.bmcl.2013.03.033] |
| 32. Mellini P, Kokkola T, Suuronen T, Salo HS, Tolvanen L, Mai A, Lahtela-Kakkonen M, Jarho EM.. (2013) Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cells.. J Med Chem, 56 (17): (6681-6695). [PMID:23927550] [10.1021/jm400438k] |
| 33. Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, Shirazi AN.. (2014) Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.. Bioorg Med Chem, 22 (2): (703-710). [PMID:24387981] [10.1016/j.bmc.2013.12.029] |
| 34. Mahajan SS, Scian M, Sripathy S, Posakony J, Lao U, Loe TK, Leko V, Thalhofer A, Schuler AD, Bedalov A, Simon JA.. (2014) Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.. J Med Chem, 57 (8): (3283-3294). [PMID:24697269] [10.1021/jm4018064] |
| 35. Khanfar MA, Quinti L, Wang H, Choi SH, Kazantsev AG, Silverman RB.. (2014) Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.. Eur J Med Chem, 76 (414-426). [PMID:24602787] [10.1016/j.ejmech.2014.02.003] |
| 36. Parenti MD, Grozio A, Bauer I, Galeno L, Damonte P, Millo E, Sociali G, Franceschi C, Ballestrero A, Bruzzone S, Del Rio A, Nencioni A.. (2014) Discovery of novel and selective SIRT6 inhibitors.. J Med Chem, 57 (11): (4796-4804). [PMID:24785705] [10.1021/jm500487d] |
| 37. Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS.. (2014) Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.. Eur J Med Chem, 83 (448-454). [PMID:24992072] [10.1016/j.ejmech.2014.06.060] |
| 38. Seifert T, Malo M, Kokkola T, Engen K, Fridén-Saxin M, Wallén EA, Lahtela-Kakkonen M, Jarho EM, Luthman K.. (2014) Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.. J Med Chem, 57 (23): (9870-9888). [PMID:25383691] [10.1021/jm500930h] |
| 39. Khanfar MA, Quinti L, Wang H, Nobles J, Kazantsev AG, Silverman RB.. (2015) Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.. ACS Med Chem Lett, 6 (5): (607-611). [PMID:26005542] [10.1021/acsmedchemlett.5b00075] |
| 40. Zang W, Hao Y, Wang Z, Zheng W.. (2015) Novel thiourea-based sirtuin inhibitory warheads.. Bioorg Med Chem Lett, 25 (16): (3319-3324). [PMID:26081291] [10.1016/j.bmcl.2015.05.058] |
| 41. Sociali G, Galeno L, Parenti MD, Grozio A, Bauer I, Passalacqua M, Boero S, Donadini A, Millo E, Bellotti M, Sturla L, Damonte P, Puddu A, Ferroni C, Varchi G, Franceschi C, Ballestrero A, Poggi A, Bruzzone S, Nencioni A, Del Rio A.. (2015) Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.. Eur J Med Chem, 102 (530-539). [PMID:26310895] [10.1016/j.ejmech.2015.08.024] |
| 42. Kumar A, Chauhan S.. (2016) How much successful are the medicinal chemists in modulation of SIRT1: A critical review.. Eur J Med Chem, 119 (45-69). [PMID:27153347] [10.1016/j.ejmech.2016.04.063] |
| 43. Chen D, Zheng W.. (2016) Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring Nε-thioacetyl-lysine.. Bioorg Med Chem Lett, 26 (21): (5234-5239). [PMID:27707605] [10.1016/j.bmcl.2016.09.055] |
| 44. Kumar R, Nigam L, Singh AP, Singh K, Subbarao N, Dey S.. (2017) Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.. Eur J Med Chem, 127 (909-916). [PMID:27836195] [10.1016/j.ejmech.2016.11.001] |
| 45. Yang LL, Wang HL, Zhong L, Yuan C, Liu SY, Yu ZJ, Liu S, Yan YH, Wu C, Wang Y, Wang Z, Yu Y, Chen Q, Li GB.. (2018) X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.. Eur J Med Chem, 155 (806-823). [PMID:29957526] [10.1016/j.ejmech.2018.06.041] |
| 46. Damonte P, Sociali G, Parenti MD, Soncini D, Bauer I, Boero S, Grozio A, Holtey MV, Piacente F, Becherini P, Sanguineti R, Salis A, Damonte G, Cea M, Murone M, Poggi A, Nencioni A, Del Rio A, Bruzzone S.. (2017) SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.. Bioorg Med Chem, 25 (20): (5849-5858). [PMID:28958848] [10.1016/j.bmc.2017.09.023] |
| 47. Li Y, Zhou Y, Wang F, Chen X, Wang C, Wang J, Liu T, Li Y, He B.. (2018) SIRT4 is the last puzzle of mitochondrial sirtuins.. Bioorg Med Chem, 26 (14): (3861-3865). [PMID:30033389] [10.1016/j.bmc.2018.07.031] |
| 48. Monaldi D, Rotili D, Lancelot J, Marek M, Wössner N, Lucidi A, Tomaselli D, Ramos-Morales E, Romier C, Pierce RJ, Mai A, Jung M.. (2019) Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma mansoni (SmSirt2).. J Med Chem, 62 (19): (8733-8759). [PMID:31496251] [10.1021/acs.jmedchem.9b00638] |
| 49. Zha GF, Rakesh KP, Manukumar HM, Shantharam CS, Long S.. (2019) Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.. Eur J Med Chem, 162 (465-494). [PMID:30469042] [10.1016/j.ejmech.2018.11.031] |
| 50. Bouchet S, Linot C, Ruzic D, Agbaba D, Fouchaq B, Roche J, Nikolic K, Blanquart C, Bertrand P.. (2019) Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.. ACS Med Chem Lett, 10 (6): (863-868). [PMID:31223439] [10.1021/acsmedchemlett.8b00440] |
| 51. Gromek SM, deMayo JA, Maxwell AT, West AM, Pavlik CM, Zhao Z, Li J, Wiemer AJ, Zweifach A, Balunas MJ.. (2016) Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.. Bioorg Med Chem, 24 (21): (5183-5196). [PMID:27614919] [10.1016/j.bmc.2016.08.040] |
| 52. Farooqi AS, Hong JY, Cao J, Lu X, Price IR, Zhao Q, Kosciuk T, Yang M, Bai JJ, Lin H.. (2019) Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.. J Med Chem, 62 (8): (4131-4141). [PMID:30986062] [10.1021/acs.jmedchem.9b00191] |
| 53. Seifert T, Malo M, Kokkola T, Stéen EJL, Meinander K, Wallén EAA, Jarho EM, Luthman K.. (2020) A scaffold replacement approach towards new sirtuin 2 inhibitors.. Bioorg Med Chem, 28 (2): (115231-115231). [PMID:31848116] [10.1016/j.bmc.2019.115231] |
| 54. Sun W, Chen X, Huang S, Li W, Tian C, Yang S, Li L.. (2020) Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.. Bioorg Med Chem Lett, 30 (16): (127215-127215). [PMID:32631504] [10.1016/j.bmcl.2020.127215] |
| 55. Chen X, Sun W, Huang S, Zhang H, Lin G, Li H, Qiao J, Li L, Yang S.. (2020) Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.. J Med Chem, 63 (18): (10474-10495). [PMID:32787077] [10.1021/acs.jmedchem.0c01183] |
| 56. Wang XX,Wan RZ,Liu ZP. (2018) Recent advances in the discovery of potent and selective HDAC6 inhibitors.. Eur J Med Chem, 143 (1406-1418). [PMID:29133060] [10.1016/j.ejmech.2017.10.040] |
| 57. Yang LL,Wang HL,Yan YH,Liu S,Yu ZJ,Huang MY,Luo Y,Zheng X,Yu Y,Li GB. (2020) Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.. Eur J Med Chem, 192 (112201-112201). [PMID:32163813] [10.1016/j.ejmech.2020.112201] |
| 58. Yagci S,Gozelle M,Kaya SG,Ozkan Y,Aksel AB,Bakar-Ates F,Dundar Y,Eren G. (2021) Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.. Bioorg Med Chem, 30 (115961-115961). [PMID:33360574] [10.1016/j.bmc.2020.115961] |
| 59. and Frye, R A RA.. (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.. Biochemical and biophysical research communications, (24): [PMID:10381378] |
| 60. Afshar, G G and Murnane, J P JP.. (1999) Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2.. Gene, (24): [PMID:10393250] |
| 61. Hu, R M RM and 28 more authors.. (2000) Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.. Proceedings of the National Academy of Sciences of the United States of America, (15): [PMID:10931946] |
| 62. Grozinger, C M CM, Chao, E D ED, Blackwell, H E HE, Moazed, D D and Schreiber, S L SL.. (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.. The Journal of biological chemistry, (19): [PMID:11483616] |
| 63. Borra, Margie T MT and 6 more authors.. (2002) Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases.. The Journal of biological chemistry, (12): [PMID:11812793] |
| 64. North, Brian J BJ, Marshall, Brett L BL, Borra, Margie T MT, Denu, John M JM and Verdin, Eric E.. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.. Molecular cell, [PMID:12620231] |
| 65. Dryden, Sylvia C SC, Nahhas, Fatimah A FA, Nowak, James E JE, Goustin, Anton-Scott AS and Tainsky, Michael A MA.. (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.. Molecular and cellular biology, [PMID:12697818] |
| 66. Hiratsuka, Masaharu M and 10 more authors.. (2003) Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene.. Biochemical and biophysical research communications, (26): [PMID:12963026] |
| 67. Bae, Nancy S NS, Swanson, Mark J MJ, Vassilev, Alex A and Howard, Bruce H BH.. (2004) Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10.. Journal of biochemistry, [PMID:15213244] |
| 68. Michishita, Eriko E, Park, Jean Y JY, Burneskis, Jenna M JM, Barrett, J Carl JC and Horikawa, Izumi I.. (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.. Molecular biology of the cell, [PMID:16079181] |
| 69. Heltweg, Birgit B and 10 more authors.. (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.. Cancer research, (15): [PMID:16618762] |
| 70. Vaquero, Alejandro A and 8 more authors.. (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.. Genes & development, (15): [PMID:16648462] |
| 71. Inoue, T T and 9 more authors.. (2007) SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.. Oncogene, (15): [PMID:16909107] |
| 72. North, Brian J BJ and Verdin, Eric E.. (2007) Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation.. The Journal of biological chemistry, (6): [PMID:17488717] |
| 73. Nahhas, Fatimah F, Dryden, Sylvia C SC, Abrams, Judith J and Tainsky, Michael A MA.. (2007) Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin.. Molecular and cellular biochemistry, [PMID:17516032] |
| 74. North, Brian J BJ and Verdin, Eric E.. (2007) Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.. PloS one, (29): [PMID:17726514] |
| 75. Jin, Yun-Hye YH and 6 more authors.. (2008) Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.. Biochemical and biophysical research communications, (11): [PMID:18249187] |
| 76. Lynn, Edward G; McLeod, Christopher J; Gordon, Jeffrey P; Bao, Jianjun and Sack, Michael N.. (2008) SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells.. FEBS letters, (20): [PMID:18640115] |
| 77. Han, Younho Y and 7 more authors.. (2008) Acetylation of Sirt2 by p300 attenuates its deacetylase activity.. Biochemical and biophysical research communications, (31): [PMID:18722353] |
| 78. Black, Joshua C JC, Mosley, Amber A, Kitada, Tasuku T, Washburn, Michael M and Carey, Michael M.. (2008) The SIRT2 deacetylase regulates autoacetylation of p300.. Molecular cell, (7): [PMID:18995842] |
| 79. Inoue, Toshiaki T and 9 more authors.. (2009) SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest.. Cell cycle (Georgetown, Tex.), (15): [PMID:19282667] |
| 80. Mayya, Viveka V and 7 more authors.. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.. Science signaling, (18): [PMID:19690332] |
| 81. Zhao, Ying Y and 9 more authors.. (2010) Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.. Nature cell biology, [PMID:20543840] |
| 82. Vempati, Rahul K RK and 5 more authors.. (2010) p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals.. The Journal of biological chemistry, (10): [PMID:20587414] |
| 83. Rothgiesser, Karin M KM, Erener, Süheda S, Waibel, Susanne S, Lüscher, Bernhard B and Hottiger, Michael O MO.. (2010) SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310.. Journal of cell science, (15): [PMID:21081649] |
| 84. Jiang, Wenqing W and 8 more authors.. (2011) Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.. Molecular cell, (8): [PMID:21726808] |
| 85. Maxwell, Michele M MM and 8 more authors.. (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.. Human molecular genetics, (15): [PMID:21791548] |
| 86. Beirowski, Bogdan B and 12 more authors.. (2011) Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling.. Proceedings of the National Academy of Sciences of the United States of America, (25): [PMID:21949390] |
| 87. Kim, Hyun-Seok HS and 15 more authors.. (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.. Cancer cell, (18): [PMID:22014574] |
| 88. Ishfaq, Muhammad M and 5 more authors.. (2012) Acetylation regulates subcellular localization of eukaryotic translation initiation factor 5A (eIF5A).. FEBS letters, (21): [PMID:22771473] |
| 89. Gal, Jiyeong J, Bang, Yeojin Y and Choi, Hyun Jin HJ.. (2012) SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition.. Neurochemistry international, [PMID:22819792] |
| 90. Park, Seong-Hoon SH and 7 more authors.. (2012) SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis.. Translational cancer research, (1): [PMID:22943040] |
| 91. Serrano, Lourdes L and 14 more authors.. (2013) The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.. Genes & development, (15): [PMID:23468428] |
| 92. Choi, You Hee YH, Kim, Hangun H, Lee, Sung Ho SH, Jin, Yun-Hye YH and Lee, Kwang Youl KY.. (2013) ERK1/2 regulates SIRT2 deacetylase activity.. Biochemical and biophysical research communications, (26): [PMID:23806683] |
| 93. Lin, Ruiting R and 7 more authors.. (2013) Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.. Molecular cell, (22): [PMID:23932781] |
| 94. Rack, Johannes G M JG, VanLinden, Magali R MR, Lutter, Timo T, Aasland, Rein R and Ziegler, Mathias M.. (2014) Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform.. Journal of molecular biology, (17): [PMID:24177535] |
| 95. Hoffmann, Gesine G, Breitenbücher, Frank F, Schuler, Martin M and Ehrenhofer-Murray, Ann E AE.. (2014) A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.. The Journal of biological chemistry, (21): [PMID:24379401] |
| 96. Yamagata, Kenichiro K and 10 more authors.. (2014) Structural basis for potent inhibition of SIRT2 deacetylase by a macrocyclic peptide inducing dynamic structural change.. Structure (London, England : 1993), (4): [PMID:24389023] |
| 97. Seo, K-S KS and 14 more authors.. (2015) SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation.. Oncogene, (12): [PMID:24681946] |
| 98. Wang, Yi-Ping YP and 14 more authors.. (2014) Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.. The EMBO journal, (17): [PMID:24769394] |
| 99. Shi, Yi Y and 7 more authors.. (2014) tRNA synthetase counteracts c-Myc to develop functional vasculature.. eLife, (17): [PMID:24940000] |
| 100. Rumpf, Tobias T and 18 more authors.. (2015) Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.. Nature communications, (12): [PMID:25672491] |
| 101. Teng, Yan-Bin YB and 7 more authors.. (2015) Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies.. Scientific reports, (23): [PMID:25704306] |
| 102. Lee, Jin-Kwan JK and 9 more authors.. (2016) Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.. Cell death & disease, (11): [PMID:27512957] |
| 103. Jing, Hui H and 6 more authors.. (2017) SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a.. eLife, (14): [PMID:29239724] |
